Posts

Showing posts from November, 2025

AI Predicts High-Dose Ivermectin and Mebendazole Combined with Supplements and Diet/Lifestyle Improved Survival in Stage 4 Prostate Cancer

Image
Abstract Background : Stage 4 prostate cancer remains largely incurable, and new strategies are urgently needed. Preclinical evidence suggests antiparasitic agents such as ivermectin and mebendazole, when combined with anti-inflammatory supplements and lifestyle changes, may offer survival benefits. Objective : To simulate the long-term efficacy and safety of a combined therapeutic protocol including high-dose ivermectin, mebendazole, nutritional supplements, and structured lifestyle changes in patients with stage 4 prostate cancer. Methods : A double-blind, randomized, placebo-controlled simulation trial was designed with 10,000 patients per arm over a 10-year follow-up. The intervention arm received high-dose ivermectin (1 mg/kg, 5x/week), mebendazole (500 mg BID), supplements (vitamin D, curcumin, omega-3, EGCG, berberine), and a structured diet/lifestyle protocol. The control arm received standard of care plus placebo. Survival outcomes and adverse event rates were simulated usi...

Evidence-Based Strategies for Cancer Prevention: I-Prevent Cancer Protocol (2025 Edition)

Image
Abstract Cancer remains a leading cause of mortality worldwide, with incidence rates projected to rise significantly in the coming decades. While advances in treatment have modestly improved survival, prevention through modifiable risk factors remains underemphasized. This review synthesizes current evidence on the role of diet, lifestyle, and dietary supplements in cancer prevention, drawing on systematic reviews, meta-analyses, and major guideline recommendations. The I-PREVENT CANCER protocol is introduced as a practical, evidence-based framework for reducing cancer risk. Introduction Despite trillions spent on cancer research , cancer still kills around 10 million people a year and is a leading cause of death globally. The incidence of common cancers such as breast, lung, and colon cancer is expected to increase by over 75% between 2022 and 2050.  While treatment advances offer incremental improvements in survival, prevention strategies—particularly those related to diet and l...

Best Fenbendazole Dosage for Cancer in Humans: Benefits, Risks, and Guidelines (2025)

Image
What is Fenbendazole? Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (2) Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some  fenbendazole advanced cancer success stories . Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discover...